Meningitis (Neisseria meningitidis)

Overview

Plain-Language Overview

Meningitis caused by Neisseria meningitidis is a serious infection that affects the protective membranes covering the brain and spinal cord, known as the meninges. This condition primarily impacts the central nervous system and can lead to severe symptoms such as fever, headache, and a stiff neck. The infection can spread rapidly and may cause complications like seizures or brain damage if not treated promptly. It is caused by a type of bacteria called Neisseria meningitidis, which can be transmitted through close contact with respiratory droplets. Early recognition and diagnosis are critical because the disease can progress quickly and become life-threatening.

Clinical Definition

Meningitis (Neisseria meningitidis) is an acute inflammation of the meninges caused by the gram-negative diplococcus Neisseria meningitidis. The bacteria invade the bloodstream and cross the blood-brain barrier, leading to meningeal inflammation and increased intracranial pressure. This infection is a major cause of bacterial meningitis worldwide, especially in children and young adults. Clinical features include fever, neck stiffness, altered mental status, and a characteristic petechial rash due to endotoxin-mediated vascular injury. The disease can rapidly progress to septic shock and disseminated intravascular coagulation (DIC), making it a medical emergency. Early identification and treatment are essential to reduce morbidity and mortality.

Inciting Event

Nasopharyngeal colonization by Neisseria meningitidis transmitted via respiratory droplets.
Upper respiratory tract infection that facilitates bacterial invasion.
Close contact exposure such as kissing or sharing utensils with an infected person.
Breakdown of mucosal barriers due to viral infections or trauma.

Latency Period

Incubation period typically 2 to 10 days after exposure to Neisseria meningitidis.
Rapid progression of symptoms often within hours to 1-2 days after bacterial invasion.
Symptom onset can be abrupt with fever and meningeal signs developing quickly.

Diagnostic Delay

Early nonspecific symptoms such as fever and malaise mimic viral illnesses leading to misdiagnosis.
Absence of classic meningeal signs in early stages delays suspicion.
Rapid progression to severe disease can outpace diagnostic evaluation.
Failure to perform lumbar puncture promptly due to contraindications or clinical instability.

Clinical Presentation

Signs & Symptoms

Sudden onset high fever and chills
Severe headache with photophobia
Neck stiffness limiting passive flexion
Nausea and vomiting due to meningeal irritation
Petechial rash often on trunk and extremities
Altered consciousness ranging from lethargy to coma

History of Present Illness

Acute onset of high fever and headache often accompanied by neck stiffness.
Photophobia and vomiting develop as meningeal irritation worsens.
Rapid progression to altered mental status or seizures in severe cases.
Petechial or purpuric rash may appear indicating systemic endotoxemia.
Symptoms often evolve over hours to 1-2 days from initial nonspecific prodrome.

Past Medical History

History of complement deficiency or immunodeficiency increases risk and severity.
Previous episodes of meningitis may suggest underlying susceptibility.
Asplenia or splenectomy predisposes to invasive meningococcal disease.
Recent upper respiratory infections or viral illnesses that compromise mucosal defenses.

Family History

Familial complement component deficiencies (e.g., C5-C9) increase susceptibility.
Genetic predisposition to impaired immune response to encapsulated bacteria.
No direct inheritance of meningitis but familial clustering of risk factors may occur.

Physical Exam Findings

Nuchal rigidity indicating meningeal inflammation
Fever and tachycardia reflecting systemic infection
Petechial or purpuric rash characteristic of meningococcemia
Altered mental status ranging from confusion to coma
Kernig's sign and Brudzinski's sign positive due to meningeal irritation

Diagnostic Workup

Diagnostic Criteria

Diagnosis is established by lumbar puncture showing CSF pleocytosis with a predominance of neutrophils, decreased glucose, and elevated protein. Gram stain and CSF culture confirming the presence of gram-negative diplococci Neisseria meningitidis provide definitive diagnosis. Blood cultures are often positive and support the diagnosis. Additional findings may include a positive latex agglutination test for meningococcal antigens. Clinical presentation combined with these laboratory findings confirms the diagnosis.

Pathophysiology

Key Mechanisms

Colonization of the nasopharynx by Neisseria meningitidis followed by invasion into the bloodstream.
Crossing of the blood-brain barrier by bacteria leading to meningeal infection and inflammation.
Activation of the immune response causing release of cytokines and recruitment of neutrophils, resulting in meningeal edema and increased intracranial pressure.
Endotoxin (lipooligosaccharide) release triggering systemic inflammatory response and potential septic shock.
Microvascular thrombosis and hemorrhage contributing to tissue damage and complications such as purpura fulminans.

Involvement	Details
Organs	Brain is affected by inflammation causing headache, altered mental status, and risk of increased intracranial pressure.
	Spleen plays a role in clearing encapsulated bacteria like Neisseria meningitidis from the bloodstream.
	Lymph nodes are involved in the immune response and may become reactive during systemic infection.
Tissues	Meninges are the inflamed protective membranes surrounding the brain and spinal cord, leading to clinical symptoms of meningitis.
Tissues	Blood-brain barrier tissue integrity is compromised, allowing bacterial invasion and immune cell infiltration into the central nervous system.
Cells	Neutrophils are the primary immune cells infiltrating the cerebrospinal fluid causing purulent inflammation in meningitis.
	Macrophages participate in phagocytosis of bacteria and release pro-inflammatory cytokines amplifying the immune response.
	Endothelial cells of the blood-brain barrier become activated and more permeable, facilitating leukocyte migration into the meninges.
Chemical Mediators	Tumor necrosis factor-alpha (TNF-α) is a key pro-inflammatory cytokine driving meningeal inflammation and fever.
	Interleukin-1 beta (IL-1β) promotes leukocyte recruitment and contributes to blood-brain barrier disruption.
	Prostaglandins mediate fever and vasodilation during the inflammatory response in meningitis.

Treatments

Pharmacological Treatments

Ceftriaxone
- Mechanism:
  - Bactericidal action by inhibiting bacterial cell wall synthesis targeting Neisseria meningitidis.
- Side effects:
  - Allergic reactions
  - Diarrhea
  - Biliary sludging
- Clinical role:
  - First-line
Vancomycin
- Mechanism:
  - Inhibits bacterial cell wall synthesis, used empirically to cover resistant strains until susceptibility is confirmed.
- Side effects:
  - Nephrotoxicity
  - Ototoxicity
  - Red man syndrome
- Clinical role:
  - Adjunctive
Dexamethasone
- Mechanism:
  - Reduces meningeal inflammation and cerebral edema by inhibiting inflammatory cytokine production.
- Side effects:
  - Hyperglycemia
  - Gastrointestinal bleeding
  - Immunosuppression
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Immediate supportive care including airway management and oxygen supplementation to prevent hypoxia.
Intravenous fluid resuscitation to maintain hemodynamic stability and prevent shock.
Isolation precautions to prevent transmission of Neisseria meningitidis to close contacts.
Close monitoring in an intensive care setting for neurological status and complications.

Prevention

Pharmacological Prevention

Quadrivalent meningococcal conjugate vaccines (MenACWY) targeting serogroups A, C, W, and Y
Serogroup B meningococcal vaccines (MenB) for high-risk populations
Rifampin prophylaxis for close contacts to eradicate nasopharyngeal carriage
Ciprofloxacin or ceftriaxone prophylaxis as alternatives for close contacts
Prompt empiric antibiotic therapy with third-generation cephalosporins in suspected cases

Non-pharmacological Prevention

Avoidance of close contact with infected individuals to reduce transmission
Good respiratory hygiene including covering mouth and nose when coughing or sneezing
Screening and vaccination of high-risk groups such as college students and military recruits
Public health measures during outbreaks including isolation and contact tracing
Education on early symptom recognition to facilitate rapid treatment

Outcome & Complications

Complications

Septic shock due to overwhelming bacteremia
Disseminated intravascular coagulation (DIC) causing bleeding and thrombosis
Waterhouse-Friderichsen syndrome with adrenal hemorrhage and acute adrenal insufficiency
Cerebral edema leading to increased intracranial pressure
Seizures from cortical irritation or infarction

Short-term Sequelae	Long-term Sequelae
Hearing loss from cochlear nerve involvement Cognitive impairment due to acute brain injury Seizure disorders developing during acute illness Hydrocephalus secondary to impaired CSF flow Skin necrosis and gangrene from purpura fulminans	Permanent sensorineural hearing loss Neurocognitive deficits including memory and attention problems Seizure disorders persisting after recovery Limb amputations due to ischemic necrosis from DIC Chronic adrenal insufficiency if Waterhouse-Friderichsen syndrome occurred

Differential Diagnoses

Meningitis (Neisseria meningitidis) versus Streptococcus pneumoniae meningitis

Meningitis (Neisseria meningitidis)	Streptococcus pneumoniae meningitis
Gram-negative diplococci on CSF Gram stain	Gram-positive diplococci on CSF Gram stain
More common in children and young adults	More common in adults and elderly
Meningococcal vaccine targets specific serogroups	Pneumococcal conjugate vaccine reduces incidence

Meningitis (Neisseria meningitidis) versus Haemophilus influenzae type b meningitis

Meningitis (Neisseria meningitidis)	Haemophilus influenzae type b meningitis
Gram-negative diplococci on CSF Gram stain	Small gram-negative coccobacilli on CSF Gram stain
Affects older children and adolescents	Primarily affects unvaccinated infants and young children
Meningococcal vaccine targets specific serogroups	Hib conjugate vaccine dramatically reduces incidence

Meningitis (Neisseria meningitidis) versus Viral meningitis

Meningitis (Neisseria meningitidis)	Viral meningitis
Neutrophilic predominance with low glucose	Lymphocytic predominance with normal glucose
Rapid progression with risk of severe complications	Usually self-limited and less severe
CSF culture or PCR positive for Neisseria meningitidis	PCR positive for enteroviruses or HSV

Meningitis (Neisseria meningitidis) versus Tuberculous meningitis

Meningitis (Neisseria meningitidis)	Tuberculous meningitis
Neutrophilic pleocytosis with moderately low glucose	Lymphocytic pleocytosis with very low glucose and high protein
Acute onset over hours to days	Subacute to chronic progression over weeks
Positive culture or PCR for Neisseria meningitidis	Positive acid-fast bacilli stain or PCR for Mycobacterium tuberculosis

Meningitis (Neisseria meningitidis) versus Brain abscess

Meningitis (Neisseria meningitidis)	Brain abscess
Diffuse meningeal enhancement without focal mass	Ring-enhancing lesion with central necrosis on MRI/CT
Diffuse meningeal signs with rapid systemic symptoms	Focal neurological deficits develop gradually
Markedly abnormal CSF with neutrophilic pleocytosis	Often normal or mildly abnormal CSF